Apogee Therapeutics, Inc. Increase (Decrease) in Prepaid Expenses, Other
Apogee Therapeutics, Inc. (APGE) reported Increase (Decrease) in Prepaid Expenses, Other of $8.62 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2026-08-10
- Apogee Therapeutics, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2026-06-30 was $6.13M, a 141.78% increase year-over-year.
- Apogee Therapeutics, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2026-03-31 was $2.49M.
- Apogee Therapeutics, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2025-12-31 was -$1.64M, a 375.50% decline year-over-year.
- Apogee Therapeutics, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2025-09-30 was $2.11M, a 25.03% decline year-over-year.
- Apogee Therapeutics, Inc. increase (decrease) in prepaid expenses, other for fiscal 2025 was $2.11M, a 65.36% decline from fiscal 2024.
- Apogee Therapeutics, Inc. increase (decrease) in prepaid expenses, other for fiscal 2024 was $6.08M, a 118.31% increase from fiscal 2023.
- Apogee Therapeutics, Inc. increase (decrease) in prepaid expenses, other for fiscal 2023 was $2.79M.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 11 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $6.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $8.62M 10-Q · filed 2026-08-10 | $6.98M derived: sum of 3 quarters · filed 2026-08-10 | $9.09M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | $2.49M 10-Q · filed 2026-05-11 | $848.00K derived: sum of 2 quarters · filed 2026-05-11 | $2.95M derived: sum of 3 quarters · filed 2026-05-11 | $5.49M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | -$1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $464.00K derived: sum of 2 quarters · filed 2026-03-02 | $3.00M derived: sum of 3 quarters · filed 2026-08-10 | $2.11M 10-K · filed 2026-03-02 | |
| 2025-09-30 | $2.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $4.64M derived: sum of 2 quarters · filed 2026-08-10 | $3.75M 10-Q · filed 2025-11-10 | $4.34M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.64M 10-Q · filed 2026-08-10 | $2.24M derived: sum of 3 quarters · filed 2026-08-10 | $5.05M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | -$895.00K 10-Q · filed 2026-05-11 | -$299.00K derived: sum of 2 quarters · filed 2026-05-11 | $2.51M derived: sum of 3 quarters · filed 2026-05-11 | $3.72M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $596.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $3.40M derived: sum of 2 quarters · filed 2026-03-02 | $4.62M derived: sum of 3 quarters · filed 2026-03-02 | $6.08M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $2.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $4.02M derived: sum of 2 quarters · filed 2025-11-10 | $5.48M 10-Q · filed 2025-11-10 | $4.87M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $2.67M 10-Q · filed 2025-08-11 | $2.06M derived: sum of 3 quarters · filed 2026-03-02 | $3.50M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-03-31 | $1.46M 10-Q · filed 2025-05-12 | $845.00K derived: sum of 2 quarters · filed 2026-03-02 | $2.28M derived: sum of 3 quarters · filed 2026-03-02 | $4.20M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2023-12-31 | -$617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $821.00K derived: sum of 2 quarters · filed 2026-03-02 | $2.74M derived: sum of 3 quarters · filed 2026-03-02 | $2.79M 10-K · filed 2026-03-02 | |
| 2023-09-30 | $1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $3.36M derived: sum of 2 quarters · filed 2024-11-12 | $3.40M 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $1.96M 10-Q · filed 2024-08-12 | |||
| 2023-03-31 | $44.00K 10-Q · filed 2024-05-13 | ||||
| 2022-12-31 | $165.00K 10-K · filed 2024-03-05 |